Perspectives

G-20 is a digital platform for global currency exchange (FX) and cryptocurrency exchange (CX) featuring spot and derivatives trading on digital assets. Through this platform, G-20 has successfully provided clients with FX services for over a decade.

When the COVID-19 pandemic sent the economy into a free fall two years ago, the market unexpectedly witnessed a strong recovery as valuations soared to new heights through 2021…

It’s commonly known that investing in small businesses is riskier than larger, more well-established ones. In addition, people may feel discouraged by the tax costs incurred that reduce investor’s profits when their realized value increases...

Over the past few weeks, markets around the globe have experienced increasing volatilities due to escalated tensions between Ukraine and Russia. With financial sanctions being imposed on Russian enterprises, the conflict also brings uprising prices to essential commodities like crude oil and worrisome inflation signals. Meanwhile, the Federal Reserve remains confident to tackle inflation, though with caution.

Over the past two years, events like COVID-19 have strained the healthcare industry both financially and operationally. As a result, we are providing insight into how market players (banks, institutions, and investors) view this growing industry and analyzing the important changes occurring as we move into 2022.

Will Special Purpose Acquisition Companies (SPAC) in Singapore be able to capture some of the momentum that U.S SPACs have experienced? On September 3rd, 2021, the Singapore Exchange (SGX) launched new rules allowing for Special Purpose Acquisition Companies to list. Private companies can be acquired by a SPAC, allowing them to reach public markets in a quicker fashion than going through an IPO or a Direct Listing. With an ever-increasing number of companies going public through SPACs in the U.S, the SGX hopes to bring the same wave to Asia.

In 2020, Saama helped Pfizer to speed up its clinical trials on Covid-19 vaccines, and then secured a $430 million investment from the Carlyle Group and venture funds from some of the pharmaceutical industry’s biggest companies. Indeed, Saama’s Smart Application is freeing clinical data management from tedious manual work and giving them more time to contribute strategically to larger clinical research.

The global healthcare innovation has been booming for quite some years now. Investors find this sector attractive and are looking for opportunities to invest into.

The global medical devices market was valued at $532.62 billion in 2021, and it is predicted to grow at a CAGR of roughly 5.5% over the next five years, reaching $734.39 billion in 2027…